In Moderate to severe pain Buprinor 0.3mg Injection helps to relieve moderate to severe pain in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. It is given as an injection by a doctor or nurse and should not be self-administered. The dose and duration will be decided by the doctor depending on the condition you are being treated for. This will help you to go about your daily activities more easily and have a better, more active, quality of life. In Opioid (Morphine) dependence Opioids are prescribed to treat pain. With prolonged use, the body may become dependent on them and cause withdrawal symptoms, which makes it difficult to stop taking them. Buprinor 0.3mg Injection helps prevent these cravings that lead to opioid dependence and also helps the person to refrain from taking them repeatedly.
It is unsafe to consume alcohol with Buprinor 0.3mg Injection.
Buprinor 0.3mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Buprinor 0.3mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Buprinor 0.3mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Buprinor 0.3mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Buprinor 0.3mg Injection may be needed. Please consult your doctor.
Buprinor 0.3mg Injection should be used with caution in patients with liver disease. Dose adjustment of Buprinor 0.3mg Injection may be needed. Please consult your doctor. Use of Buprinor 0.3mg Injection is not recommended in patients with serious liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Torrent Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Indus Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)